Apellis Pharmaceuticals
APLS
$49.86
Share price
4.03%
Change (1 day)
-42.97%
Change (1 year)
Categories
EPS for Apellis Pharmaceuticals (APLS)
EPS in 2023 (TTM): -$5.25
According to Apellis Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$5.25. In 2022 the company made an earnings per share (EPS) of -$6.13 an increase over its 2021 EPS that were of -$8.85.
EPS history for Apellis Pharmaceuticals from 2017 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$5.25 | -14.36% |
| 2022 | -$6.13 | -30.73% |
| 2021 | -$8.85 | 92.81% |
| 2020 | -$4.59 | -11.73% |
| 2019 | -$5.20 | 123.18% |
| 2018 | -$2.33 | 27.08% |
| 2017 | -$1.83 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -58.48% | 🇺🇸 USA |